Castle Biosciences CSTL Business Segments — Other segment items
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's business segments — other segment items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's business segments — other segment items?
- Castle Biosciences (CSTL) reported business segments — other segment items of $12.25M in Q1 2026.
- How has Castle Biosciences's business segments — other segment items changed year-over-year?
- Castle Biosciences's business segments — other segment items decreased by 66.9% year-over-year, from $37.02M to $12.25M.
- What is the long-term trend for Castle Biosciences's business segments — other segment items?
- Over 3 years (2022 to 2025), Castle Biosciences's business segments — other segment items has grown at a 95.2% compound annual growth rate (CAGR), from $8.8M to $65.5M.
- What does business segments — other segment items mean?
- Encompasses miscellaneous operating expenses or income items specific to the segment that do not fall into primary cost categories. Tracking this helps identify non-recurring or secondary operational impacts on segment performance.